Literature DB >> 15033785

Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis.

Teodora Niculescu1, Susanna Weerth, Lucian Soane, Florin Niculescu, Violeta Rus, Cedric S Raine, Moon L Shin, Horea Rus.   

Abstract

Complement activation is involved in the initiation of inflammation and antibody-mediated demyelination in experimental autoimmune encephalomyelitis (EAE). We investigated the role of MAC in apoptosis in myelin-induced EAE in complement C5-deficient (C5-d) and C5-sufficient (C5-s) mice. The number of apoptotic cells assessed by TUNEL assay was significantly increased in C5-d mice during clinical recovery as compared with C5-s mice. Most of the apoptotic cells were lymphocytes, monocytes, and oligodendrocytes. DNA microarray was performed using total RNA extracted from spinal cords. Genes expressed higher in C5-s included members of the caspase (caspase 6, 7), TNF and TNFR families (CD27, FasL, lymphotoxin-beta R) and survivin. These results indicate that C5 and possibly MAC may be required for the limitation of inflammatory response within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15033785     DOI: 10.1196/annals.1299.098

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Inhibition of C5a receptor alleviates experimental CNS lupus.

Authors:  Alexander Jacob; Bradley Hack; Tao Bai; James R Brorson; Richard J Quigg; Jessy J Alexander
Journal:  J Neuroimmunol       Date:  2010-03-05       Impact factor: 3.478

2.  C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB.

Authors:  Alexander Jacob; Bradley Hack; Peili Chen; Richard J Quigg; Jessy J Alexander
Journal:  J Neurochem       Date:  2011-10-20       Impact factor: 5.372

3.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.

Authors:  Susanna H Weerth; Horea Rus; Moon L Shin; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

4.  Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury.

Authors:  Manuel D Galvan; Sabina Luchetti; Adrian M Burgos; Hal X Nguyen; Mitra J Hooshmand; Frank P T Hamers; Aileen J Anderson
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

5.  Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.

Authors:  Arnab Chakravarti; Michelle DeSilvio; Min Zhang; David Grignon; Seth Rosenthal; Sucha O Asbell; Gerald Hanks; Howard M Sandler; Li-Yan Khor; Alan Pollack; William Shipley
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

Review 6.  The role of the complement system in Multiple Sclerosis: A review.

Authors:  Nil Saez-Calveras; Olaf Stuve
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

7.  The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue.

Authors:  Peng Chen; Bing Liu; Ming Hu
Journal:  Oncol Lett       Date:  2013-01-07       Impact factor: 2.967

8.  Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.

Authors:  Philip F Stahel; Michael A Flierl; B Paul Morgan; Ivonne Persigehl; Christiane Stoll; Claudia Conrad; Basel M Touban; Wade R Smith; Kathryn Beauchamp; Oliver I Schmidt; Wolfgang Ertel; Iris Leinhase
Journal:  J Neuroinflammation       Date:  2009-01-08       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.